IgG is the most abundantly found immunoglobulin to be produced in response to an antigen and will be maintained in the body after initial exposure for long term response.
Cat. No. GLKT1032 Novel Coronavirus COVID-19 IgG ELISA kit
| Principle | Indirect Method |
| Sample type | Serum |
| Sample volume | 10 μL |
| Assay incubation | 80 minutes, RT |
| Total Wash Steps | 2 |
| Limit of detection | 5 IU/mL |
| Repeatability | CV < 15% |
| Reproducibility | CV < 20% |
IgM is the first immunoglobulin to be produced in response to an antigen and will be primarily detectable during the early onset of the disease. This ELISA kit is designed, developed, and produced for the qualitative measurement of the COVID-19 IgM antibody in serum. This assay utilizes the “IgM capture” method on microplate based enzyme immunoassay technique.
Cat. No. GLKT1033 Novel Coronavirus COVID-19 IgM ELISA kit
| Principle | Capture Method |
| Sample type | Serum |
| Sample volume | 20 μL |
| Assay incubation | 80 minutes, 37ºC |
| Total Wash Steps | 2 |
| Limit of detection | 5 IU/mL |
| Repeatability | CV < 15% |
| Reproducibility | CV < 20% |
The following papers have cited the use of EDI™ Novel Coronavirus COVID-19 IgG or IgM ELISA kits:
Jeffrey D. Whitman, et al. Test performance evaluation of SARS-CoV-2 serological assays. MedRXiv. Published 2020 Apr 29. doi:10.1101/2020.04.25.20074856 [Not certified by peer review]
This study was conducted using deviations to the instructions for use and with inadequate conditions. For additional information, please view the statement from Epitope Diagnostics, Inc. on the validity of the study.
